September 2025 - QuartzBio

Stay abreast of the latest life sciences applications of AI at:

“GenAI Roadmap: Transforming the Future of Healthcare & Life Sciences”

October 9, 2025

At this interactive event, Amazon Web Services (AWS) partner organizations will explore how GenAI is reshaping the future of health — from bench to bedside.

Tobi Guennel, Ph.D., QuartzBio’s Chief Technology Officer, will present use cases showing how R&D organizations are leveraging agentic frameworks and multi-agent networks to scale GenAI’s impact on every aspect of precision medicine development.

View the full agenda and speaker lineup: https://www.aws-partner-events.com/gen-ai-conference-healthcare-and-lifesciences/

Attending the BiotechX USA conference in Philadelphia? It’s the premier conference for R&D teams who understand the impact of digital transformation across the entire precision medicine value chain.

Stop by booth #603 to chat with QuartzBio’s Precision Medicine AI Agents. We’ll demonstrate how our AI agents act as secure, personalized virtual assistants, delivering Sample and Biomarker Intelligence Solutions for translational research, informatics, sample/biomarker operations, and IT teams.

These agents help you with everyday tasks such as finding data, answering questions, surfacing analytics, and prescriptive recommendations for risk-mitigating actions.

See how you can unlock 10X faster access to insights and a >2X boost in team productivity, accelerating study close and time-to-market.

Book your personalized booth demo here.

Precision for Medicine is the first biomarker-driven clinical development organization supporting life sciences companies in the use of biomarkers essential to targeting patient treatments. Precision for Medicine is part of Precision Medicine Group, with 3,000 employees in 40 locations.

Web Design and Development by RainCastle Communications.